MENU
+Compare
MEDX
ETF ticker: NASDAQ
AS OF
Jan 21 closing price
Price
$26.17
Change
+$0.42 (+1.63%)
Net Assets
15.31M

MEDX stock forecast, quote, news & analysis

Category: @Health
MEDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for MEDX with price predictions
Jan 08, 2025

MEDX in +1.20% Uptrend, advancing for three consecutive days on January 03, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MEDX advanced for three days, in of 132 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MEDX's RSI Indicator exited the oversold zone, of 15 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 25 cases where MEDX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MEDX just turned positive on January 03, 2025. Looking at past instances where MEDX's MACD turned positive, the stock continued to rise in of 16 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MEDX as a result. In of 29 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MEDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MEDX entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB).

Industry description

The investment seeks to provide long-term growth of capital. The fund is an actively-managed exchange-traded fund (“ETF”) that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.

Market Cap

The average market capitalization across the Horizon Kinetics Medical ETF ETF is 86.89B. The market cap for tickers in the group ranges from 3.93M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is SLRX at 3.93M.

High and low price notable news

The average weekly price growth across all stocks in the Horizon Kinetics Medical ETF ETF was 2%. For the same ETF, the average monthly price growth was -1%, and the average quarterly price growth was -14%. LTRN experienced the highest price growth at 17%, while BCYC experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Horizon Kinetics Medical ETF ETF was -1%. For the same stocks of the ETF, the average monthly volume growth was -62% and the average quarterly volume growth was -16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 78
Price Growth Rating: 65
SMR Rating: 75
Profit Risk Rating: 78
Seasonality Score: -43 (-100 ... +100)
View a ticker or compare two or three
MEDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Listed Funds Trust490 Royal Lake DriveCape Girardeau
Phone
N/A
Web
N/A